| Index | S&P 500 | P/E | 195.15 | EPS (ttm) | -0.03 | Insider Own | 0.53% | Shs Outstand | 118.00M | Perf Week | -1.90% |
| Market Cap | 11.05B | Forward P/E | 9.62 | EPS next Y | 9.74 | Insider Trans | -2.62% | Shs Float | 117.61M | Perf Month | -13.47% |
| Enterprise Value | 11.40B | PEG | 34.59 | EPS next Q | - | Inst Own | 92.10% | Short Float | 10.00% | Perf Quarter | -19.38% |
| Income | 224.00M | P/S | 1.87 | EPS this Y | - | Inst Trans | 0.00% | Short Ratio | 5.13 | Perf Half Y | -50.26% |
| Sales | 5.91B | P/B | 1.05 | EPS next Y | -12.41% | ROA | 1.41% | Short Interest | 11.76M | Perf YTD | -33.77% |
| Book/sh | 89.27 | P/C | 6.77 | EPS next 5Y | 5.75% | ROE | 2.26% | 52W High | 221.02 -57.62% | Perf Year | 2.63% |
| Cash/sh | 13.83 | P/FCF | 8.23 | EPS past 3/5Y | - | ROIC | 3.34% | 52W Low | 88.01 6.43% | Perf 3Y | -38.73% |
| Dividend Est. | 1.64 (1.75%) | EV/EBITDA | 10.57 | Sales past 3/5Y | -11.10% 10.45% | Gross Margin | 23.89% | Volatility | 2.74% 2.91% | Perf 5Y | -59.05% |
| Dividend TTM | 1.63 (1.73%) | EV/Sales | 1.93 | EPS Y/Y TTM | 99.73% | Oper. Margin | 11.92% | ATR (14) | 3.67 | Perf 10Y | 16.45% |
| Dividend Ex-Date | Sep 11, 2026 | Quick Ratio | 1.35 | Sales Y/Y TTM | 9.85% | Profit Margin | 3.79% | RSI (14) | 28.67 | Recom | 2.64 |
| Dividend Gr. 3/5Y | 0.84% 1.02% | Current Ratio | 2.09 | EPS Q/Q | 3309.09% | SMA20 | -6.62% | Beta | 1.35 | Target Price | 167.09 |
| Payout | 159.43% | Debt/Eq | 0.34 | Sales Q/Q | 31.05% | SMA50 | -19.11% | Rel Volume | 0.66 | Prev Close | 92.54 |
| Employees | 7,800 | LT Debt/Eq | 0.33 | Earnings | Nov 04 | SMA200 | -38.31% | Avg Volume | 2.38M | Price | 93.67 |
| IPO Date | Feb 22, 1994 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 17.09% 8.49% | Net Debt/EBITDA | 0.33 | Volume | 1,569,772 | Change | 1.22% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-20-26 | Reiterated | Truist Securities | Buy | $225 → $185 |
| Oct-15-26 | Reiterated | RBC Capital | Outperform | $166 → $129 |
| Oct-14-26 | Upgrade | Mizuho | Neutral → Outperform | |
| Oct-12-26 | Initiated | Barclays | Equal Weight | $109 |
| Oct-07-26 | Reiterated | Argus Research | Buy | $230 → $135 |
| Oct-06-26 | Reiterated | BMO Capital | Outperform | $200 → $175 |
| Oct-05-26 | Reiterated | UBS | Buy | $175 → $150 |
| Oct-01-26 | Reiterated | Mizuho | Neutral | $185 → $130 |
| Aug-10-26 | Reiterated | Morgan Stanley | Equal Weight | $189 → $161 |
| Aug-10-26 | Reiterated | Scotiabank | Sector Outperform | $215 → $190 |
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,908 | 5,143 | 5,378 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,496 | 4,471 | 5,317 | — | — | — | — | — | — | |
| Gross Profit | 1,412 | 672 | 60 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 540 | 526 | 610 | — | — | — | — | — | — | |
| Research and Development | 38 | 51 | 87 | — | — | — | — | — | — | |
| Other Operating Expense | 128 | 1 | -1 | — | — | — | — | — | — | |
| Operating Income | 705 | 94 | -636 | — | — | — | — | — | — | |
| Interest Expense | 173 | 208 | 166 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -258 | -194 | -247 | — | — | — | — | — | — | |
| Net Income Before Taxes | 273 | -308 | -1,048 | — | — | — | — | — | — | |
| Income Taxes | 90 | 157 | 87 | — | — | — | — | — | — | |
| Consolidated Net Income | 224 | -511 | -1,179 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 182 | -465 | -1,135 | — | — | — | — | — | — | |
| Net Income | 224 | -511 | -1,179 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.48 | -5.75 | -11.20 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.48 | -5.75 | -11.20 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.03 | -5.75 | -11.20 | — | — | — | — | — | — | |
| EBITDA | 1,079 | 558 | -294 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.87 | 3.25 | 1.89 | — | — | — | — | — | — | |
| Gross Margin | 23.90 | 13.07 | 1.12 | — | — | — | — | — | — | |
| Operating Margin | 11.93 | 1.83 | -11.83 | — | — | — | — | — | — | |
| Net Margin | 3.79 | -9.94 | -21.92 | — | — | — | — | — | — | |
| Shares Outstanding | 118 | 118 | 118 | — | — | — | — | — | — | |
| Market Capitalization | 11,053 | 16,690 | 10,157 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Masters J Kent | Chairman & CEO | May 15 '26 | Sale | 183.72 | 16,393 | 3,011,766 | 87,519 | May 19 |
| Masters J Kent | Chairman & CEO | Mar 10 '26 | Sale | 170.81 | 11,783 | 2,012,689 | 134,628 | Mar 12 |
| Norris Eric | Chief Commercial Officer | Feb 20 '26 | Sale | 165.45 | 5,692 | 941,741 | 48,819 | Feb 23 |
| STEINER GERALD A | Director | Feb 18 '26 | Option Exercise | 0.00 | 934 | 0 | 11,946 | Feb 20 |
| Anderson Melissa H. | Chief Bus..Transformation Off. | Feb 13 '26 | Sale | 163.71 | 8,454 | 1,384,004 | 9,439 | Feb 18 |
| Sheorey Neal Ravi | Chief Financial Officer | Nov 06 '25 | Option Exercise | 0.00 | 1,953 | 0 | 13,064 | Nov 10 |
| Krupa Ander C. | General Counsel & Sec | Oct 24 '25 | Sale | 105.00 | 172 | 18,060 | 11,483 | Oct 28 |
| Krupa Ander C. | General Counsel & Sec | Oct 09 '25 | Sale | 95.00 | 116 | 11,020 | 11,655 | Oct 14 |
| LaBauve Donald J. Jr. | VP, Corporate Controller & CAO | Feb 27 '25 | Option Exercise | 0.00 | 522 | 0 | 5,447 | Feb 28 |
| Johnson Netha N. | Chief Operations Officer | Feb 27 '25 | Option Exercise | 0.00 | 3,518 | 0 | 43,133 | Feb 28 |
| Masters J Kent | Chairman & CEO | Feb 27 '25 | Option Exercise | 0.00 | 16,932 | 0 | 122,096 | Feb 28 |
| Mummert Mark Richard | Chief Supply Chain Officer | Feb 27 '25 | Option Exercise | 0.00 | 522 | 0 | 7,091 | Feb 28 |
| Anderson Melissa H. | Chief People Officer | Feb 27 '25 | Option Exercise | 0.00 | 2,866 | 0 | 13,182 | Feb 28 |
| Norris Eric | Chief Commercial Officer | Feb 27 '25 | Option Exercise | 0.00 | 3,518 | 0 | 47,615 | Feb 28 |
| Anderson Melissa H. | Chief People Officer | Jan 01 '25 | Option Exercise | 0.00 | 1,194 | 0 | 10,715 | Jan 03 |